Ramipace tablets 1.25mg





Ramipace tablets 1.25mg is primarily indicated in conditions like Benign gastric ulcer associated with H.pylori, Congestive heart failure (adjunct), Gastric acid reduction during anaesthesia, Heart failure, Hypertension, Iron deficiency anaemia, Mild to moderate hypertension, Prophylaxis of cardiovascular events/stroke.

Side Effects 

The severe or irreversible adverse effects of Ramipace tablets 1.25mg, which give rise to further complications include Angioedema., Ramipace tablets 1.25mg produces potentially life-threatening effects which include Renal failure, Hypotension, which are responsible for the discontinuation of Ramipace tablets 1.25mg therapy.,The signs and symptoms that are produced after the acute overdosage of Ramipace tablets 1.25mg include Hypotension, Renal insufficiency., The symptomatic adverse reactions produced by Ramipace tablets 1.25mgare more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Diarrhea, Rashes, Nausea and vomiting.


Ramipace tablets 1.25mg is contraindicated in conditions like Salt depletion,Hypotension, Arterial stenosis.


Ramipace tablets 1.25mg should be used with caution in patients with a history of angioedema, high blood levels of potassium, kidney disease or kidney dialysis, salt restrictive diet or liver disease Consult the doctor before rising salt


There are no reviews yet.

Be the first to review “Ramipace tablets 1.25mg”

Your email address will not be published. Required fields are marked *